New Jersey joins states that allow medical cannabis as opioid alternative

What’s the right revenue per square foot? What’s a realistic business outlook for cultivators? Get realistic market forecasts, state-by-state insights and benchmarks. Get the 2023 Factbook.

New Jersey Gov. Phil Murphy’s administration has added opioid addiction to the list of qualifying conditions that are treatable with medical marijuana, a move that could provide a boost to MMJ sales.

In 2015, New Jersey health care providers wrote 55 opioid prescriptions per 100 persons, or 4.9 million prescriptions, according to the National Institute on Drug Abuse.

The addition of opioid addiction mirrors what other states, including neighboring New York and Pennsylvania, have done.

Murphy, a Democrat, has expanded the state’s MMJ program since he took office a year ago, and the number of patients has more than doubled to 39,000.

Last March, he added five new qualifying conditions, including anxiety, migraines, Tourette syndrome and two types of chronic pain.

An expected influx of new patients comes as the state is preparing for the opening of six new dispensaries, which doubles the existing number.

– Associated Press and Marijuana Business Daily